Anu Moilanen

Title: Anu Moilanen: Innovator in Androgen Receptor Modulation

Introduction

Anu Moilanen is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of androgen receptor modulators. With a focus on innovative compounds, her work aims to address critical health issues, including prostate cancer and male hypogonadism.

Latest Patents

Anu Moilanen holds 2 patents that showcase her expertise in creating novel therapeutic compounds. Her latest patents include "Androgen receptor modulating carboxamides," which disclose compounds of specific formulas that possess utility as tissue-selective androgen receptor modulators (SARM). These compounds are particularly useful as medicaments in the treatment of prostate cancer and other conditions where androgen receptor antagonism is desired. Another significant patent is for "Propionamide derivatives useful as androgen receptor modulators," which details compounds that can be utilized in hormonal therapy, especially for the treatment or prevention of male hypogonadism and age-related conditions such as andropause.

Career Highlights

Anu Moilanen is associated with Orion Corporation, a leading pharmaceutical company in Finland. Her work at Orion has allowed her to focus on the development of innovative therapies that have the potential to improve patient outcomes in various androgen-dependent conditions.

Collaborations

Anu collaborates with esteemed colleagues, including Olli Törmäkangas and Gerd Wohlfahrt. These partnerships enhance her research and development efforts, contributing to the advancement of therapeutic solutions in her field.

Conclusion

Anu Moilanen's contributions to the field of androgen receptor modulation highlight her role as a key innovator in medicinal chemistry. Her patents reflect her commitment to developing effective treatments for significant health challenges.